Data sourced from ClinicalTrials.gov (NIH registry) Updated weekly IRB-supervised studies only
Home/GA/Athens
Updated October 2026 from ClinicalTrials.gov

Paid Clinical Trials in Athens, GA

Studies commonly pay $75 to $4,500 per completed study

71 clinical trials are currently recruiting participants within 30 miles of Athens. Listings below come straight from the official NIH registry, alongside the area's top-rated research centers with real Google reviews.

71studies recruiting
9+research centers nearby
4condition categories
Live from the NIH registry

Studies recruiting near Athens right now

Top 25 of 71 recruiting studies, sorted by proximity — each links to its official registry page

Study Comparing AAA817+ARPI Versus Standard of Care in Adult Participants With PSMA-positive mCRPC

Prostate Cancer Phase 3 Interventional 940 participants sought
University Cancer and Blood Center LLC — Athens, Georgia (0.9 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06855277)

Artificial Intelligence Mapping and Ablation of Non-Pulmonary Vein Electrical Drivers of AF Study

Atrial Fibrillation (AF) N/A Interventional 423 participants sought
Piedmont Heart of Athens — Athens, Georgia (0.9 mi) · Sponsor: Vektor Medical
See eligibility & contact on ClinicalTrials.gov (NCT06935591)

A Clinical Study to Find the Optimal Dose of an Investigational Treatment Called BNT323 When Used in Combination With Another Investigational Treatment, BNT327, and to Test if That Combination Treatment is Safe and Beneficial for Patients With Advanced Breast Cancer

Locally Advanced Breast Cancer, Unresectable Breast Carcinoma Phase 1, Phase 2 Interventional 380 participants sought
University Cancer & Blood Center, LLC — Athens, Georgia (0.9 mi) · Sponsor: BioNTech SE
See eligibility & contact on ClinicalTrials.gov (NCT06827236)

Delivering Transcutaneous Auricular Neurostimulation to Reduce Blood Loss During Dialysis AV Graft Placement Procedures

Blood Loss, Surgical N/A Interventional 40 participants sought
University Surgical Vascular — Watkinsville, Georgia (6.5 mi) · Sponsor: University Surgical Vascular
See eligibility & contact on ClinicalTrials.gov (NCT06647017)

A Study of Amivantamab and FOLFIRI Versus Cetuximab/Bevacizumab and FOLFIRI in Participants With KRAS/NRAS and BRAF Wild-type Colorectal Cancer Who Have Previously Received Chemotherapy

Colorectal Neoplasms Phase 3 Interventional 700 participants sought
University Cancer And Blood Center LLC — Athens, Georgia (0.9 mi) · Sponsor: Janssen Research & Development, LLC
See eligibility & contact on ClinicalTrials.gov (NCT06750094)

Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)

NSCLC (Non-small Cell Lung Cancer), Non-Small Cell Lung Cancer Phase 3 Interventional 590 participants sought
University Cancer and Blood Center — Athens, Georgia (0.9 mi) · Sponsor: Revolution Medicines, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT06881784)

A Study to Evaluate Mezigdomide, Bortezomib and Dexamethasone (MEZIVd) Versus Pomalidomide, Bortezomib and Dexamethasone (PVd) in Participants With Relapsed or Refractory Multiple Myeloma (RRMM)

Relapsed or Refractory Multiple Myeloma Phase 3 Interventional 810 participants sought
Local Institution - 0211 — Athens, Georgia (0.9 mi) · Sponsor: Celgene
See eligibility & contact on ClinicalTrials.gov (NCT05519085)

A Global Study Comparing Pulsed Field Ablation With Electrographic Flow Mapping Versus Posterior Wall Ablation for Persistent Atrial Fibrillation

Atrial Fibrillation (AF), Persistant Atrial Fibrillation N/A Interventional 699 participants sought
Piedmont Athens Regional — Athens, Georgia (0.9 mi) · Sponsor: Boston Scientific Corporation
See eligibility & contact on ClinicalTrials.gov (NCT07187115)

Study to Evaluate Sutetinib Maleate Capsule in Locally Advanced or Metastatic Non-small Cell Lung Cancer

Non-small Cell Lung Cancer Phase 2 Interventional 128 participants sought
University Cancer & Blood Center — Athens, Georgia (0.9 mi) · Sponsor: Teligene US
See eligibility & contact on ClinicalTrials.gov (NCT05168566)

A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung, Neoplasm Metastasis Phase 3 Interventional 1,264 participants sought
University Cancer & Blood Center, LLC — Athens, Georgia (0.9 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT06119581)

A Study to Investigate the Efficacy and Safety of Dato-DXd With or Without Osimertinib Compared With Platinum Based Doublet Chemotherapy in Participants With EGFR-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer

Metastatic Non-small Cell Lung Cancer Phase 3 Interventional 744 participants sought
Research Site — Athens, Georgia (0.9 mi) · Sponsor: AstraZeneca
See eligibility & contact on ClinicalTrials.gov (NCT06417814)

Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])

Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma Phase 3 Interventional 1,210 participants sought
Northeast Georgia Medical Center Braselton — Braselton, Georgia (25.1 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT04267848)

Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy

Prostate Cancer Phase 2, Phase 3 Interventional 443 participants sought
University Cancer and Blood Center LLC — Athens, Georgia (0.9 mi) · Sponsor: Novartis Pharmaceuticals
See eligibility & contact on ClinicalTrials.gov (NCT06780670)

Renewed Recovery: a Pilot Test of a Web-Based Mindfulness-Based Relapse Prevention Continuing Care Intervention for Alcohol Use Disorder

Alcohol Use Disorder (AUD) N/A Interventional 30 participants sought
Project Adam — Winder, Georgia (20.3 mi) · Sponsor: University of Georgia
See eligibility & contact on ClinicalTrials.gov (NCT06987526)

LEVEL-2: LEVosimendan to Improve Exercise Limitation in Patients With PH-HFpEF-2

Pulmonary Hypertension Associated With HFpEF Phase 3 Interventional 540 participants sought
Tenax Investigational Site — Athens, Georgia (0.9 mi) · Sponsor: Tenax Therapeutics, Inc.
See eligibility & contact on ClinicalTrials.gov (NCT07288398)

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

Breast Cancer Phase 3 Interventional 3,960 participants sought
University Cancer and Blood Center LLC — Athens, Georgia (0.9 mi) · Sponsor: NRG Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05879926)

A Study To Assess the Safety, Tolerability, and Efficacy of Imzokitug in Combination With Pumitamig and Platinum-Doublet Chemotherapy (PDCT) Versus Pumitamig and PDCT as First-line Treatment for Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)

Locally Advanced Non-Small Cell Lung Cancer (NSCLC), Metastatic Non-Small Cell Lung Cancer (NSCLC) Phase 2 Interventional 160 participants sought
University Cancer & Blood Center, LLC — Athens, Georgia (0.9 mi) · Sponsor: Bristol-Myers Squibb
See eligibility & contact on ClinicalTrials.gov (NCT07680764)

Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma

Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma Phase 2 Interventional 81 participants sought
University Cancer and Blood Center LLC — Athens, Georgia (0.9 mi) · Sponsor: National Cancer Institute (NCI)
See eligibility & contact on ClinicalTrials.gov (NCT05112601)

Pembrolizumab vs. Observation in People With Triple-negative Breast Cancer Who Had a Pathologic Complete Response After Chemotherapy Plus Pembrolizumab

Anatomic Stage II Breast Cancer AJCC v8, Early Stage Triple-Negative Breast Carcinoma Phase 3 Interventional 1,295 participants sought
University Cancer and Blood Center LLC — Athens, Georgia (0.9 mi) · Sponsor: Alliance for Clinical Trials in Oncology
See eligibility & contact on ClinicalTrials.gov (NCT05812807)

Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer

Carcinoma, Non-Small-Cell Lung Phase 3 Interventional 700 participants sought
University Cancer & Blood Center, LLC — Athens, Georgia (0.9 mi) · Sponsor: Eli Lilly and Company
See eligibility & contact on ClinicalTrials.gov (NCT06890598)

A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)

Triple Negative Breast Neoplasms Phase 3 Interventional 1,000 participants sought
University Cancer & Blood Center, LLC ( Site 0023) — Athens, Georgia (0.9 mi) · Sponsor: Merck Sharp & Dohme LLC
See eligibility & contact on ClinicalTrials.gov (NCT06841354)
Actively enrolling

Studies you may be able to join near Athens

These studies are recruiting through partner research networks. We may be paid a referral fee if you complete their screening form — this never changes what you pay (nothing) or the compensation the study offers you.

See which clinical studies you may qualify for

A partner research network matches volunteers with studies that are currently enrolling in the United States. You answer a few screening questions about your health and where you live; if a study looks like a fit, its team contacts you to confirm eligibility.

Screening is free and takes a few minutes. Eligibility and any compensation are confirmed by the study team, not by this site.

Check your eligibility
Google-rated

Top-rated research centers in Athens

Dedicated clinical research sites near you — with their real Google ratings, reviews and contact details

Clinical & Translational Research Unit (CTRU)

★ 4.8
109 Bowstrom Road, Athens, GA 30606
(706) 713-2721
"Also a research participant in a study, not only were the staff experienced and knowledgeable about their field, but they were incredibly kind indivi…"
— Jacob Yoo, 5★

Athena Clinical Research

2005 Prince Ave, Athens, GA 30606
(706) 208-9700

Summit Clinical Research

★ 1.0
3320 Old Jefferson Rd Bldg.400, Athens, GA 30607
(706) 400-4262
"I was in or trying to be in a Liver study with Summit clinical I was doing everything they asked me to do. And because the owner of the facility did …"
— Robin Greenlee, 1★

Complex Carbohydrate Research Center

★ 4.8
CCRC, 315 Riverbend Rd, Athens, GA 30602
(706) 542-4401
"CCRC at the University of Georgia is an excellent research center with world-class facilities, supportive faculty, and a highly collaborative environ…"
— Bijoyananda Mishra, 5★

UGA Center for Tropical and Emerging Global Diseases (CTEGD)

500 D. W. Brooks Drive Ste 335, Athens, GA 30605
(706) 542-3688

UGA Biomechanics Lab

Ramsey Student Center, 330 River Rd Rm 103, Athens, GA 30602
(706) 542-4132

Poultry Diagnostic & Research Center

★ 5.0
953 College Station Rd, Athens, GA 30602
(706) 542-1904
"Helping keep our food supplies safe"
— Jane Cunningham, 5★

University of Georgia Office of Research

150, 500 D. W. Brooks Drive, Athens, GA 30602
(706) 542-5969

Lighthouse Neuropsychology

★ 4.7
575 Research Dr Ste B, Athens, GA 30605
(706) 850-9339
"5 stars isn't enough! My Aunt was referred by her psychologist to Lighthouse Neuropsychology. Dr. Finley was patient, warm, and so good at putting my…"
— Cheryl Ford-Jones, 5★

Clinical trials in Athens: what's recruiting

The Athens area currently has 71 studies open to new participants, according to the ClinicalTrials.gov registry maintained by the U.S. National Institutes of Health. Among the studies closest to Athens, the most active research areas are:

  • Cancer & Oncology15 studies
  • Diabetes & Metabolism1 studies
  • Heart & Vascular1 studies
  • Lungs & Breathing1 studies

Every listing shows the study phase, the recruiting site and its distance from Athens, and links to the official registry page where eligibility criteria and study contacts are published. Compensation is set by each sponsor: industry surveys report typical payments of $75 to $4,500 per completed study, with short observational studies at the low end and multi-visit or overnight Phase 1 studies at the high end.

How to enroll in a paid study in Athens

Start with a study whose condition matches your profile — or a healthy-volunteer study if you have no diagnosis. Contact the research site through the registry page, complete a short phone screen, then attend an in-person screening visit. If you qualify, the study team walks you through the informed consent document, which details every procedure, risk and payment before you commit. You can withdraw at any point, and enrollment is always free.

Athens participants can also register with the dedicated research centers listed above — many maintain volunteer databases and call when a matching study opens — or sign up for our email alert below to hear when a new study starts recruiting within 30 miles of your ZIP code.

Frequently asked questions

How much do paid clinical trials in Athens pay?
Compensation varies by study length, procedures and overnight stays. Industry surveys report typical payments from $75 to $4,500 per completed study, with simple observational studies at the low end and multi-week inpatient Phase 1 studies at the high end. Each listing's study team will confirm the exact amount before you enroll.
Do I need to be sick to join a clinical trial in Athens?
No. Many studies recruit healthy volunteers, especially early-phase studies run at dedicated research centers. Others need participants diagnosed with a specific condition. Every trial lists its eligibility criteria — age range, condition, medications — and the study team screens you before enrollment.
Are clinical trials in Athens safe?
Every trial on this page is registered on ClinicalTrials.gov, the official NIH registry, and is overseen by an Institutional Review Board (IRB). Before joining you receive an informed consent document detailing procedures, risks and compensation. Participation is voluntary and you can withdraw at any time.
How do I join a study in Athens, GA?
Pick a study that matches your profile, contact the research site (or apply through the study links on this page), pass a phone pre-screen, then attend an in-person screening visit. If you qualify, you review and sign the informed consent and the study begins. The process typically takes 1-3 weeks.
Can I be in more than one clinical trial at a time?
Generally no — most studies exclude participants currently enrolled in another trial, and paid Phase 1 studies enforce a washout period (often 30 days or more) between studies. Frequent healthy volunteers in Athens typically complete one or two studies per year.

Paid clinical trials near Athens

Other metros within reach

Gainesville, GA146 Atlanta, GA1,713 Macon, GA75 Greenville, SC382 Mauldin, SC380 Warner Robins, GA75 Augusta, GA184 Spartanburg, SC366

By condition

Eligibility and exclusions, condition by condition

Alcoholic Liver Disease in Athens Bladder Issues Due To Spinal Cord Injury in Athens All conditions

More of GA

Atlanta1,713 Augusta184 Savannah171 Gainesville146 Macon75 Warner Robins75 Columbus68

New paid studies open every week

Get an email when a new clinical trial starts recruiting within 30 miles of your ZIP code. No spam — only real studies from the NIH registry.

By subscribing you agree to receive study alert emails. Unsubscribe anytime in one click.

Get free trial alerts